Anti-SARS‐CoV‐2 Repurposing Drug Database: Clinical Pharmacology Considerations

• Main Authors: Xinyuan Zhang (Author), Yuching Yang (Author), Manuela Grimstein (Author), Guansheng Liu (Author), Eliford Kitabi (Author), Jianghong Fan (Author), Ying‐Hong Wang (Author), Justin Earp (Author), James L. Weaver (Author), Hao Zhu (Author), Jiang Liu (Author), Kellie S. Reynolds (Author), Shiew‐Mei Huang (Author), Yaning Wang (Author)
• Format: Book
• Published: Wiley, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The Anti-SARS‐CoV‐2 Repurposing Drug Database is a database that includes both in vitro anti-SARS‐CoV‐2 activity and in vivo pharmacokinetic...